← 產業報告目錄
ATMPs Consulting Market Size, Share & Trends Analysis Report By Phase (Early-Stage Development, Clinical Development, Commercialization), By Type (Gene therapy medicinal products, Somatic cell medicinal products, Tissue-engineered medicinal products), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-29頁數 180報告編號 INSIGHTACE-c72c7ae7d4
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide ATMPs Consulting Market is expected to register a CAGR of 8.6%.
ATMPs Consulting covers human medicines based on genes, tissues, or cells. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is driven by rising interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advanced Therapy Medicinal Products (ATMPs) Consulting Market Snapshot
Chapter 4. Global Advanced Therapy Medicinal Products (ATMPs) Consulting Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Phase Estimates & Trend Analysis
5.1. By Phase, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Phase:
5.2.1. Early-Stage Development
5.2.2. Clinical Development
5.2.3. Commercialization
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
6.2.1. Gene therapy medicinal products
6.2.2. Somatic cell medicinal products
6.2.3. Tissue-engineered medicinal products
Chapter 7. Advanced Therapy Medicinal Products (ATMPs) Consulting Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts By Phase, 2021-2034
7.1.2. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
7.1.3. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, 2021-2034
7.2.2. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, 2021-2034
7.2.3. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, 2021-2034
7.3.2. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, 2021-2034
7.3.3. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, (US$ Million) 2021-2034
7.4.2. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
7.4.3. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, (US$ Million) 2021-2034
7.5.2. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
7.5.3. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Dark Horse Consulting
8.2.2. PharmaLex (Acquired by AmerisourceBergen)
8.2.3. ProPharma Group
8.2.4. Clarkston Consulting
8.2.5. Alacrita Life Science Consulting
8.2.6. Kinesys Consulting
8.2.7. Voisin Consulting Life Sciences (VCLS)
8.2.8. QbD Group (Michor Consulting/EUDRAC)
8.2.9. Advanced Cell & Gene Therapy
8.2.10. Validant/DataRevive
8.2.11. Asphalion
8.2.12. Putnam
8.2.13. Other Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們